{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T16:23:47Z","timestamp":1788020627718,"version":"build-2784847793"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5,1]]},"DOI":"10.1513\/annalsats.201701-055ed","type":"journal-article","created":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T15:32:53Z","timestamp":1493652773000},"page":"621-623","source":"Crossref","is-referenced-by-count":19,"title":["Minimizing Tuberculosis Risk in Patients Receiving Anti-TNF Therapy"],"prefix":"10.1093","volume":"14","author":[{"given":"Hanif","family":"Esmail","sequence":"first","affiliation":[{"name":"Wellcome Center for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine and Department of Medicine, University of Cape Town, Cape Town, South Africa"},{"name":"Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2753-1800","authenticated-orcid":false,"given":"Robert J.","family":"Wilkinson","sequence":"additional","affiliation":[{"name":"Wellcome Center for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine and Department of Medicine, University of Cape Town, Cape Town, South Africa"},{"name":"Department of Medicine, Imperial College London, London, United Kingdom; and"},{"name":"The Francis Crick Institute, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,5,1]]},"reference":[{"key":"2026020403062006700_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2010.04146.x","article-title":"How tumour necrosis factor blockers interfere with tuberculosis immunity","volume":"161","author":"Harris","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"2026020403062006700_bib2","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1056\/NEJMcp1005750","article-title":"Clinical practice: latent tuberculosis infection in the United States","volume":"364","author":"Horsburgh","year":"2011","journal-title":"N Engl J Med"},{"key":"2026020403062006700_bib3","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/rheumatology\/kei103","article-title":"British Thoracic Society (BTS) recommendations for assessing risk and managing tuberculosis in patients due to start anti\u2013TNF-\u03b1 treatments","volume":"44","author":"Ledingham","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"2026020403062006700_bib4","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"N Engl J Med"},{"key":"2026020403062006700_bib5","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1183\/09031936.00028510","article-title":"The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement","volume":"36","author":"Solovic","year":"2010","journal-title":"Eur Respir J"},{"key":"2026020403062006700_bib6","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/MIB.0000000000001003","article-title":"Tuberculosis screening and reactivation among a national cohort of patients with inflammatory bowel disease treated with tumor necrosis factor alpha antagonists","volume":"23","author":"Hou","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"2026020403062006700_bib7","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1513\/AnnalsATS.201608-647OC","article-title":"Efficacy of treatment for latent tuberculosis in patients undergoing treatment with a tumor necrosis factor antagonist","volume":"14","author":"Lee","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"2026020403062006700_bib8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.4046\/trd.2015.78.2.56","article-title":"Diagnosis and treatment of latent tuberculosis infection","volume":"78","author":"Lee","year":"2015","journal-title":"Tuberc Respir Dis (Seoul)"},{"key":"2026020403062006700_bib9","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.3748\/wjg.v21.i11.3308","article-title":"Significant risk and associated factors of active tuberculosis infection in Korean patients with inflammatory bowel disease using anti-TNF agents","volume":"21","author":"Kim","year":"2015","journal-title":"World J Gastroenterol"},{"key":"2026020403062006700_bib10","doi-asserted-by":"crossref","first-page":"20130437","DOI":"10.1098\/rstb.2013.0437","article-title":"The ongoing challenge of latent tuberculosis","volume":"369","author":"Esmail","year":"2014","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"2026020403062006700_bib11","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/thoraxjnl-2013-203436","article-title":"Evaluation of screening methods for identification of patients with chronic rheumatological disease requiring tuberculosis chemoprophylaxis prior to commencement of TNF-\u03b1 antagonist therapy","volume":"68","author":"Singanayagam","year":"2013","journal-title":"Thorax"},{"key":"2026020403062006700_bib12","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1002\/ibd.21605","article-title":"Prednisolone treatment affects the performance of the QuantiFERON gold in-tube test and the tuberculin skin test in patients with autoimmune disorders screened for latent tuberculosis infection","volume":"17","author":"B\u00e9lard","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"2026020403062006700_bib13","doi-asserted-by":"crossref","first-page":"e1000160","DOI":"10.1371\/journal.ppat.1000160","article-title":"Origin, spread and demography of the Mycobacterium tuberculosis complex","volume":"4","author":"Wirth","year":"2008","journal-title":"PLoS Pathog"},{"key":"2026020403062006700_bib14","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1128\/CVI.05299-11","article-title":"Comparison of two gamma interferon release assays and tuberculin skin testing for tuberculosis screening in a cohort of patients with rheumatic diseases starting anti-tumor necrosis factor therapy","volume":"18","author":"Vassilopoulos","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"2026020403062006700_bib15","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/art.22768","article-title":"Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection","volume":"57","author":"G\u00f3mez-Reino","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2026020403062006700_bib16","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1186\/s12879-016-1875-6","article-title":"QuantiFERON conversion following tuberculin administration is common in HIV infection and relates to baseline response","volume":"16","author":"Esmail","year":"2016","journal-title":"BMC Infect Dis"},{"key":"2026020403062006700_bib17","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/ecco-jcc\/jjw129","article-title":"Negative screening does not rule out the risk of tuberculosis in patients with inflammatory bowel disease undergoing anti-TNF treatment: a descriptive study on the GETAID cohort","volume":"10","author":"Abitbol","year":"2016","journal-title":"J Crohn\u2019s Colitis"},{"key":"2026020403062006700_bib18","first-page":"S2213-2600(16)30419-2","article-title":"From latent to patent: rethinking prediction of tuberculosis","volume":"pii","author":"Cobelens","year":"2016","journal-title":"Lancet Respir Med"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/14\/5\/621\/66714036\/annalsats_14_5_621.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/14\/5\/621\/66714036\/annalsats_14_5_621.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T08:06:28Z","timestamp":1770192388000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/14\/5\/621\/8454356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,1]]},"references-count":18,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,5,1]]},"published-print":{"date-parts":[[2017,5,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.201701-055ed","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,5]]},"published":{"date-parts":[[2017,5,1]]}}}